Fasting and cancer: Starving the beast
DENIAL, famously, is good for the soul. It is also good for the body.(20)
Money talks: October 10th 2011: A spoonful of sugar
The aftermath of the Solyndra scandal, recapitalising Europe's banks and how to sell cold medicines, which do not cure colds(1)
Cancer drugs: Big Pharma's gripes about the FDA
Genentech's battle with the regulator over Avastin, an expensive cancer treatment, will be the first of many(13)
Drug companies in America: The costly war on cancer
New cancer drugs are technically impressive. But must they cost so much?(37)
Prevention of cancer: Wonder drug
Aspirin continues to amaze(16)
South Africa and AIDS: Getting to grips
The government is beginning to make some headway against AIDS(5)
The XVIII International AIDS Society meeting: Waltzing with death
AIDS still kills 2m people a year. But the rate of new infections is falling and it is possible to imagine bringing the disease under control(18)
South Africa and HIV/AIDS: Setting a better example
Despite his sometimes ambiguous attitude, President Jacob Zuma has been tested for HIV and his government’s policy has improved(9)
Cancer therapy: Stemming the tumorous tide
Cancers grow from stem cells. That discovery should translate into better treatment for tumours of all types(10)
Pharmaceuticals: Shock to the system
Cholesterol drugs are under attack(0)
South Africa: In the (beetroot) soup, again
More allegations against the hapless health minister(0)
AIDS in India: Not half as bad
The latest estimates suggest HIV is less prevalent in India than was feared(0)
Pharmaceuticals: On the block?
Legal victories may leave Bristol-Myers Squibb exposed to a takeover bid(0)
Drugs directed at precise molecular targets are helping cancer patients live longer. They have yet, however, to fulfil all expectations(0)
Brazil's AIDS programme: A conflict of goals
Helping patients, or science(0)
Cancer therapy: Choose your poison
A new test picks the chemotherapy most suited to the tumour(0)
Cancer therapy: Re-establishing control
The first of a new class of drugs gains regulatory approval(0)
Pharmaceuticals: Dispensed with
Yet another boss of a big drugs company loses his job(0)
Why are drug patents now coming under legal attack?(0)
South Africa: Beetroot but no blushes
More controversy over AIDS policy(0)
For the first time since the epidemic began, money to fight AIDS is in plentiful supply. It is now time to convert words into action(0)
The battle over generic drugs heats up(0)
Testing drugs is dangerous(0)
Advertisement
Over the past five days
Over the past seven days
Advertisement